Poh CF - Search Results

1

Toluidine blue staining identifies high-risk primary oral premalignant lesions with poor outcome.

Zhang L, Williams M, Poh CF, Laronde D, Epstein JB, Durham S, Nakamura H, Berean K, Hovan A, Le ND, Hislop G, Priddy R, Hay J, Lam WL, Rosin MP. Zhang L, et al. Among authors: poh cf. Cancer Res. 2005 Sep 1;65(17):8017-21. doi: 10.1158/0008-5472.CAN-04-3153. Cancer Res. 2005. PMID: 16140975

2

Use of allelic loss to predict malignant risk for low-grade oral epithelial dysplasia.

Rosin MP, Cheng X, Poh C, Lam WL, Huang Y, Lovas J, Berean K, Epstein JB, Priddy R, Le ND, Zhang L. Rosin MP, et al. Clin Cancer Res. 2000 Feb;6(2):357-62. Clin Cancer Res. 2000. PMID: 10690511

3

High frequency of allelic loss in dysplastic lichenoid lesions.

Zhang L, Cheng X, Li Y, Poh C, Zeng T, Priddy R, Lovas J, Freedman P, Daley T, Rosin MP. Zhang L, et al. Lab Invest. 2000 Feb;80(2):233-7. doi: 10.1038/labinvest.3780026. Lab Invest. 2000. PMID: 10701692 Free article.

4

A high frequency of allelic loss in oral verrucous lesions may explain malignant risk.

Poh CF, Zhang L, Lam WL, Zhang X, An D, Chau C, Priddy R, Epstein J, Rosin MP. Poh CF, et al. Lab Invest. 2001 Apr;81(4):629-34. doi: 10.1038/labinvest.3780271. Lab Invest. 2001. PMID: 11304582 Free article.

5

Increased genetic damage in oral leukoplakia from high risk sites: potential impact on staging and clinical management.

Zhang L, Cheung KJ Jr, Lam WL, Cheng X, Poh C, Priddy R, Epstein J, Le ND, Rosin MP. Zhang L, et al. Cancer. 2001 Jun 1;91(11):2148-55. doi: 10.1002/1097-0142(20010601)91:11<2148::aid-cncr1243>3.0.co;2-g. Cancer. 2001. PMID: 11391596

6

Impact of localized treatment in reducing risk of progression of low-grade oral dysplasia: molecular evidence of incomplete resection.

Zhang L, Poh CF, Lam WL, Epstein JB, Cheng X, Zhang X, Priddy R, Lovas J, Le ND, Rosin MP. Zhang L, et al. Among authors: poh cf. Oral Oncol. 2001 Sep;37(6):505-12. doi: 10.1016/s1368-8375(00)00140-8. Oral Oncol. 2001. PMID: 11435177

7

Vulvar squamous cell carcinoma in young women: a clinicopathologic study of 21 cases.

Al-Ghamdi A, Freedman D, Miller D, Poh C, Rosin M, Zhang L, Gilks CB. Al-Ghamdi A, et al. Gynecol Oncol. 2002 Jan;84(1):94-101. doi: 10.1006/gyno.2001.6466. Gynecol Oncol. 2002. PMID: 11748983

8

Comparison of HPV infection, p53 mutation and allelic losses in post-transplant and non-posttransplant oral squamous cell carcinomas.

Zhang L, Epstein JB, Poh CF, Berean K, Lam WL, Zhang X, Rosin MP. Zhang L, et al. Among authors: poh cf. J Oral Pathol Med. 2002 Mar;31(3):134-41. doi: 10.1034/j.1600-0714.2002.310302.x. J Oral Pathol Med. 2002. PMID: 11903818

9

3p14 and 9p21 loss is a simple tool for predicting second oral malignancy at previously treated oral cancer sites.

Rosin MP, Lam WL, Poh C, Le ND, Li RJ, Zeng T, Priddy R, Zhang L. Rosin MP, et al. Cancer Res. 2002 Nov 15;62(22):6447-50. Cancer Res. 2002. PMID: 12438233

10

Increased allelic loss in toluidine blue-positive oral premalignant lesions.

Epstein JB, Zhang L, Poh C, Nakamura H, Berean K, Rosin M. Epstein JB, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003 Jan;95(1):45-50. doi: 10.1067/moe.2003.97. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003. PMID: 12539026 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

94 results

Search Page

Filters